High Frequency QRS Analysis for Ischemia Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current ECG analysis methods for detecting myocardial ischemia, particularly through high frequency components of the QRS complex, face challenges in accurately identifying relative reductions in amplitude during stress conditions, which are indicative of ischemia or infarction, often resulting in false negatives or requiring multiple tests.

Innovation Solution

The proposed solution involves an apparatus and method that quantify features in the QRST waveform by analyzing high frequency components above 100 Hz, using a combination of primary and secondary HF analyzers to derive indices from ECG signals, and applying a decision algorithm to detect relative and absolute reductions in amplitude, thereby diagnosing ischemia or infarction with improved accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional ECG analysis methods are used to detect myocardial ischemia, then the detection process is simple, but the accuracy is low resulting in false negatives

Engineering Contradiction:
Improveischemia detection accuracyVSAvoidanalysis system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the QRS complex analysis into multiple frequency components, specifically isolating high frequency components (HFC) above 100 Hz from the conventional ECG signal. This segmentation allows independent analysis of different frequency bands, enabling detection of ischemia through HFC amplitude changes without being confounded by lower frequency components, thereby improving detection accuracy while maintaining manageable system complexity through modular signal processing

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a new dimension of analysis by examining the amplitude of high frequency components as a separate diagnostic parameter beyond conventional ECG metrics. This dimensional expansion adds the HFC amplitude measurement (a new parameter space) to the traditional ECG analysis framework, enabling detection of ischemia through changes in this additional dimension without requiring complete replacement of existing analysis methods

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If high frequency component analysis is implemented, then detection accuracy improves, but the device complexity increases

Engineering Contradiction:
Improveischemia detection accuracyVSAvoidsignal processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary signal processing actions including band-pass filtering to isolate high frequency components before main analysis, and averaging of multiple cardiac cycles to enhance signal quality. These preliminary actions prepare the signal in advance, reducing noise and artifacts before the actual ischemia detection algorithm is applied, thereby improving measurement precision while keeping the core detection logic relatively simple

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces complex mechanical or invasive diagnostic procedures with electronic signal processing methods. Specifically, it substitutes physical stress testing or invasive monitoring with non-invasive ECG-based high frequency component analysis, using computational methods to extract diagnostic information from routine ECG signals, thus improving accuracy without proportionally increasing physical device complexity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If relative amplitude reduction detection is used, then false negatives are reduced, but the requirement for stress condition monitoring increases

Engineering Contradiction:
Improvediagnosis reliabilityVSAvoidtesting efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent enables continuous monitoring of high frequency component amplitude during stress conditions, allowing real-time detection of ischemia without requiring intermittent or repeated testing. The continuous acquisition and analysis of HFC amplitude provides an uninterrupted diagnostic stream, improving reliability by capturing transient ischemic events while maintaining testing efficiency through automated real-time analysis rather than requiring multiple discrete test sessions

Inventive Principle:
Principle #20Continuity of useful action

4Measurement precision

If multiple ECG parameters are analyzed, then diagnostic accuracy improves, but the time required for analysis increases

Engineering Contradiction:
Improvediagnosis accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent extracts and focuses specifically on the high frequency component amplitude parameter from the full ECG signal spectrum, isolating this single most diagnostic parameter for ischemia detection. By extracting only the relevant HFC amplitude information rather than analyzing all ECG parameters equally, the system maintains high diagnostic accuracy while reducing analysis time, as the focused extraction allows rapid calculation without processing unnecessary parameters

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS8862211B2Apparatus and method for identifying myocardial ischemia using analysis of high frequency QRS potentials
Publication Date: 2014.10.14 BSP MEDICAL LTD
  • US8862211B2 patent drawing
  • US8862211B2 patent drawing
  • US8862211B2 patent drawing

AI summary

Detecting cardiac ischemia by detecting local changes in high frequency ECG parameters. Local changes may be, for example, local reduction in RMS of high frequency components, for example, during a stress test.